3rd Quarter - Report

WILLIAMS AND JENSEN, PLLC for PHRMA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures Initiative, H.R. 6.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
CHERYL LYNN JAEGER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Budget/Appropriations BUD

Issues related to pharmaceutical development.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep Van Hilleary and Majority Whip
CHERYL LYNN JAEGER Shrd employee, Ofc of the Speaker & Ofc of VA 7; Sr Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Republican Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Roy Blunt; Prof Staff House Committee E&C; SR LA Rep Cox.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

General education about policies impacting pharmaceutical development, approval and reimbursement. Non-interference. Rebates for Medicare Part D. Importation. 340B Drug Pricing Program. 21st Century Cures Initiative. H.R. 2 Medicare Access and CHIP Reauthorization Act of 2015. H.R. 1021, Protecting the Integrity of Medicare Act. CMMI Medicare Part B Demonstration.

LobbyistCovered position, as disclosed
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
ANDREW JONES Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep. Lujan
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —
FRANK VLOSSAK LA, Rep. Merrill Cook

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1021 (114th), H.R. 2 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.